Singapore-based facility management company AcroMeta Group Limited has announced a strategic move into the cell and gene therapy logistics sector through a non-binding term sheet with Macro HRD SG Pte. Ltd. The agreement outlines a partnership with Macro-ATCLS Pte. Ltd., which is commercializing Macro's Ambient Temperature Cellular Logistics (ATCLS) technology. This technology aims to eliminate the need for traditional cold chains in transporting living cells and other temperature-sensitive biological materials.
The proposed partnership would give AcroMeta an option to acquire an exclusive license to deploy the ATCLS platform across Southeast Asia, including the right to appoint sub-licensees. This structure allows AcroMeta to secure exclusive rights in the region and a first right to acquire additional territories, significantly expanding its potential commercial reach. Lawrence Toh, Executive Director of AcroMeta, stated that the move is a natural extension of the company's strategy to grow its portfolio beyond core operations, and they are excited about the potential to build a meaningful presence in Southeast Asia.
The ATCLS technology uses proprietary ambient-temperature preservation and reactivation methods, supported by a Gradient Equilibrium Decision Modeling (GEDM) platform for real-time governance, chain-of-identity, and process control. This enables dormant living cells to be transported at ambient temperature and reactivated at the point of use, potentially reducing costs, fragility, and geographic limitations associated with conventional cold-chain logistics.
The market opportunity is substantial, with the global cell-and-gene-therapy third-party logistics (3PL) market estimated at US$1.81 billion in 2025 and projected to reach US$16.95 billion by 2035, a compound annual growth rate of 25.1%. ATCLS estimates a Serviceable Addressable Market (SAM) of approximately US$14.5 billion by 2032 for defined ambient-addressable segments. These figures were provided by Macro's management and have not been independently verified by AcroMeta's board.
The Group will continue to evaluate strategic opportunities that support its long-term growth, emphasizing disciplined capital allocation. This partnership marks a significant step in AcroMeta's evolution from its core facility management services into high-growth sectors. For more information on AcroMeta, visit www.AcroMeta.com.
